Literature DB >> 15796958

BRCA1 and pancreatic cancer: pedigree findings and their causal relationships.

Henry T Lynch1, Carolyn A Deters, Carrie L Snyder, Jane F Lynch, Pierre Villeneuve, Julie Silberstein, Holly Martin, Steven A Narod, Randall E Brand.   

Abstract

Anecdotal reports and series studies indicate that 5-10% of pancreatic cancer (PC) cases are familial. In addition, PC is associated with a variety of hereditary cancer syndromes. PC appears to be an integral cancer in the hereditary breast-ovarian cancer (HBOC) syndrome, with most notice given to the role of BRCA2. Our purpose is to call attention to BRCA1, which also predisposes to PC. Using data from our familial breast cancer registry, we identified 19 BRCA1/2 families that contain PC affecteds in the pedigrees, 15 with BRCA1 mutations and 4 with BRCA2 mutations. The association between BRCA2 and pancreatic cancer is well established; however, a definite link with pancreatic cancer in families carrying a BRCA1 mutation has been far less studied. Thus, the focus of this report is on 9 of the 15 BRCA1 families, in which PC affecteds were either confirmed carriers of the BRCA1 mutation or were inferred as probable obligate BRCA1 mutation carriers. The numbers are small, but nevertheless illustrate the finding of others of an apparent association between PC and BRCA1-mutation-bearing families. Given the dismal prognosis of PC, with the only current hope for survival being through surgical extirpation of the pancreas prior to metastasis, it is prudent that we realize the potential predisposition toward PC via BRCA1, in the hope of early diagnosis and prevention.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15796958     DOI: 10.1016/j.cancergencyto.2004.01.032

Source DB:  PubMed          Journal:  Cancer Genet Cytogenet        ISSN: 0165-4608


  38 in total

Review 1.  Review of screening for pancreatic cancer in high risk individuals.

Authors:  Alina Stoita; Ian D Penman; David B Williams
Journal:  World J Gastroenterol       Date:  2011-05-21       Impact factor: 5.742

2.  Role of BRCA1 and BRCA2 mutations in pancreatic cancer.

Authors:  Julia B Greer; David C Whitcomb
Journal:  Gut       Date:  2006-09-14       Impact factor: 23.059

Review 3.  Genetic predisposition to pancreatic cancer.

Authors:  Paola Ghiorzo
Journal:  World J Gastroenterol       Date:  2014-08-21       Impact factor: 5.742

4.  Advances in counselling and surveillance of patients at risk for pancreatic cancer.

Authors:  Randall E Brand; Markus M Lerch; Wendy S Rubinstein; John P Neoptolemos; David C Whitcomb; Ralph H Hruban; Teresa A Brentnall; Henry T Lynch; Marcia I Canto
Journal:  Gut       Date:  2007-10       Impact factor: 23.059

5.  Contribution of germline mutations in the BRCA and PALB2 genes to pancreatic cancer in Italy.

Authors:  P Ghiorzo; V Pensotti; G Fornarini; S Sciallero; L Battistuzzi; F Belli; L Bonelli; G Borgonovo; W Bruno; A Gozza; S Gargiulo; L Mastracci; S Nasti; G Palmieri; F Papadia; L Pastorino; A Russo; V Savarino; L Varesco; L Bernard; G Bianchi Scarrà
Journal:  Fam Cancer       Date:  2012-03       Impact factor: 2.375

Review 6.  Pancreatic cancer early detection: expanding higher-risk group with clinical and metabolomics parameters.

Authors:  Shiro Urayama
Journal:  World J Gastroenterol       Date:  2015-02-14       Impact factor: 5.742

7.  Prevalence and characteristics of pancreatic cancer in families with BRCA1 and BRCA2 mutations.

Authors:  Daniel H Kim; Beth Crawford; John Ziegler; Mary S Beattie
Journal:  Fam Cancer       Date:  2008-10-15       Impact factor: 2.375

8.  Clinical and pathological characteristics of Chinese patients with BRCA related breast cancer.

Authors:  Ava Kwong; L P Wong; H N Wong; F B F Law; E K O Ng; Y H Tang; W K Chan; D T K Suen; C Choi; L S Ho; K H Kwan; M Poon; T T Wong; K Chan; S W W Chan; M W L Ying; W C Chan; E S K Ma; J M Ford; D W West
Journal:  Hugo J       Date:  2010-04-10

9.  Germline BRCA1 mutations predispose to pancreatic adenocarcinoma.

Authors:  Wigdan Al-Sukhni; Heidi Rothenmund; Ayelet Eppel Borgida; George Zogopoulos; Anne-Marie O'Shea; Aaron Pollett; Steven Gallinger
Journal:  Hum Genet       Date:  2008-09-02       Impact factor: 4.132

10.  Asymptomatic pancreatic lesions: new insights and clinical implications.

Authors:  Martin Loos; Christoph W Michalski; Jörg Kleeff
Journal:  World J Gastroenterol       Date:  2012-09-07       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.